Study and analysis of antitumor resistance mechanism of PD1/PD‐L1 immune checkpoint blocker-Reference-Cited by-同舟云学术

Study and analysis of antitumor resistance mechanism of PD1/PD‐L1 immune checkpoint blocker

Published:2020-09-02 Issue:21 Volume:9 Page:8086-8121
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Wang Zhengyi¹²^ORCID,Wu Xiaoying³

Affiliation:

1. GCP Center of Sichuan Academy of Medical Sciences and Sichuan Provincial People’s Hospital Medical Sciences Chengdu City Sichuan Province China

2. Institute of Laboratory Animals of Sichuan Academy of Medical Sciences and Sichuan Provincial People’s Hospital Chengdu City Sichuan Province China

3. Ministry of Education and Training Second People’s Hospital Chengdu City Sichuan Province China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3410

Reference249 articles.

1. Cancer immunotherapy using checkpoint blockade

2. Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysis

3. The future of immune checkpoint therapy

4. Immune cell profiling in the age of immune checkpoint inhibitors: implications for biomarker discovery and understanding of resistance mechanisms

5. Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Roles of the tumor microenvironment in the resistance to programmed cell death protein 1 inhibitors in patients with gastric cancer;World Journal of Gastrointestinal Oncology;2024-09-15

3. Targeting Dual Immune Checkpoints PD‐L1 and HLA‐G by Trispecific T Cell Engager for Treating Heterogeneous Lung Cancer;Advanced Science;2024-09-05

4. Infiltrating treg reprogramming in the tumor immune microenvironment and its optimization for immunotherapy;Biomarker Research;2024-09-04

5. Effects of PD-L1 Inhibitors on Mitochondrial Function in Melanoma A375 Cells: Unveiling a Shielded Drug Resistance Mechanism;2024-08-09